Chilton R - Search Results

1

New options for the treatment of obesity and type 2 diabetes mellitus (narrative review).

Henry RR, Chilton R, Garvey WT. Henry RR, et al. Among authors: chilton r. J Diabetes Complications. 2013 Sep-Oct;27(5):508-18. doi: 10.1016/j.jdiacomp.2013.04.011. Epub 2013 May 28. J Diabetes Complications. 2013. PMID: 23726071 Free PMC article. Review.

2

Myocardial considerations in type 2 diabetes: 2018.

Chilton R, Lin C, Gallegos KM, Pham S. Chilton R, et al. J Diabetes. 2018 Oct;10(10):784-788. doi: 10.1111/1753-0407.12788. Epub 2018 Jul 22. J Diabetes. 2018. PMID: 30033584 No abstract available.

3

Lipids as risk markers for type 2 diabetes.

Bloomgarden Z, Chilton R. Bloomgarden Z, et al. Among authors: chilton r. J Diabetes. 2019 Mar;11(3):176-178. doi: 10.1111/1753-0407.12880. Epub 2018 Dec 18. J Diabetes. 2019. PMID: 30479008 No abstract available.

4

Diabetes and stroke: An important complication.

Bloomgarden Z, Chilton R. Bloomgarden Z, et al. Among authors: chilton r. J Diabetes. 2021 Mar;13(3):184-190. doi: 10.1111/1753-0407.13142. Epub 2020 Dec 27. J Diabetes. 2021. PMID: 33300237 No abstract available.

5

Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes.

Chilton RJ, Dungan KM, Shubrook JH, Umpierrez GE. Chilton RJ, et al. Prim Care Diabetes. 2020 Jun;14(3):193-212. doi: 10.1016/j.pcd.2019.09.008. Epub 2019 Nov 6. Prim Care Diabetes. 2020. PMID: 31704161 Free article. Review.

6

Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes.

Chilton RJ. Chilton RJ. Diabetes Obes Metab. 2020 Jan;22(1):16-29. doi: 10.1111/dom.13854. Epub 2019 Aug 30. Diabetes Obes Metab. 2020. PMID: 31407866 Review.

7

Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?

Abdul-Ghani M, DeFronzo RA, Del Prato S, Chilton R, Singh R, Ryder REJ. Abdul-Ghani M, et al. Among authors: chilton r. Diabetes Care. 2017 Jul;40(7):813-820. doi: 10.2337/dc16-2736. Diabetes Care. 2017. PMID: 28637886 Free PMC article.

8

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus.

Neeland IJ, McGuire DK, Chilton R, Crowe S, Lund SS, Woerle HJ, Broedl UC, Johansen OE. Neeland IJ, et al. Among authors: chilton r. Diab Vasc Dis Res. 2016 Mar;13(2):119-26. doi: 10.1177/1479164115616901. Diab Vasc Dis Res. 2016. PMID: 26873905 Free PMC article. Clinical Trial.

9

Cardiovascular comorbidities of type 2 diabetes mellitus: defining the potential of glucagonlike peptide-1-based therapies.

Chilton R, Wyatt J, Nandish S, Oliveros R, Lujan M. Chilton R, et al. Am J Med. 2011 Jan;124(1 Suppl):S35-53. doi: 10.1016/j.amjmed.2010.11.004. Am J Med. 2011. PMID: 21194579 Review.

10

The cardiovascular effects of GLP-1 receptor agonists.

Okerson T, Chilton RJ. Okerson T, et al. Cardiovasc Ther. 2012 Jun;30(3):e146-55. doi: 10.1111/j.1755-5922.2010.00256.x. Epub 2010 Dec 19. Cardiovasc Ther. 2012. PMID: 21167014 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page